Accelerate Diagnostics Stock Price

0.00 (0.0%)
Upgrade to Real-Time
Afterhours (Closed)
Volume 191,900
Bid Price 4.90
Ask Price 5.30
News -
Day High 5.02


52 Week Range


Day Low 4.88
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Accelerate Diagnostics Inc AXDX NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.0% 4.93 20:00:00
Open Price Low Price High Price Close Price Prev Close
5.01 4.88 5.02 4.93 4.93
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
2,322 191,900 $ 4.98 $ 954,904 - 4.71 - 15.60
Last Trade Time Type Quantity Stock Price Currency
17:39:09 64 $ 4.93 USD


Draw Mode:

Accelerate Diagnostics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 343.45M 69.66M 43.27M $ 11.16M $ - -1.40 -3.80
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 967.45k 6.20%

more financials information »

Accelerate Diagnostics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical AXDX Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week5.215.214.714.94399,286-0.28-5.37%
1 Month6.237.194.715.53600,777-1.30-20.87%
3 Months5.927.194.715.77425,145-0.99-16.72%
6 Months8.209.364.716.23282,562-3.27-39.88%
1 Year7.2115.604.718.57343,484-2.28-31.62%
3 Years14.1124.004.5312.12312,678-9.18-65.06%
5 Years22.2030.454.5316.40308,729-17.27-77.79%

Accelerate Diagnostics Description

Accelerate Diagnostics Inc is an in vitro diagnostics company that specializes in rapid diagnostics for infectious pathogens. The firm's core platform, the Accelerate ID/AST System, determines whether live bacterial or fungal cells in a patient sample are susceptible to a particular antibiotic. This test is performed on pathogens that are commonly associated with serious infections and can deliver results more quickly than traditional methods, such as bacterial culturing. The system can analyze a positive blood culture sample in approximately five hours, which is faster than traditional testing techniques.

Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.